Cited by 668Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsDNA and Nucleic Acid Chemistry

Role of Telomeres and Telomerase in Aging and Cancer

Open access
Shay, Jerry W.·2016·Cancer Discovery

Abstract

Telomeres progressively shorten throughout life. A hallmark of advanced malignancies is the ability for continuous cell divisions that almost universally correlates with the stabilization of telomere length by the reactivation of telomerase. The repression of telomerase and shorter telomeres in humans may have evolved, in part, as an anticancer protection mechanism. Although there is still much we do not understand about the regulation of telomerase, it remains a very attractive and novel target for cancer therapeutics. This review focuses on the current state of advances in the telomerase area, identifies outstanding questions, and addresses areas and methods that need refinement. Significance: Despite many recent advances, telomerase remains a challenging target for cancer therapy. There are few telomerase-directed therapies, and many of the assays used to measure telomeres and telomerase have serious limitations. This review provides an overview of the current state of the field and how recent advances could affect future research and treatment approaches. Cancer Discov; 6(6); 584–93. ©2016 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-16-0062

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The pathogenicity of telomere shortening in ageing is an antagonistic pleiotropic effect of a trait selected for early benefits such as limiting proliferation and tumor formation.

    “The pathogenicity of telomere shortening in ageing is an antagonistic pleiotropic effect of a trait that must have been selected for its early benefits such as limiting unrestrainted proliferation and hence tumor formation14.”

    From The central role of DNA damage in the ageing process (2021) · cites this paper as [14]

  • TERT silencing downregulates telomerase activity in human somatic cells.

    “TERT silencing downregulates telomerase activity in human somatic cells (reviewed in REF. 22).”
  • Most malignancies aim to maintain a sufficient length of telomeres in order to enhance their duplication rate and survival.

    “Notably, most malignancies aim to maintain a sufficient length of telomeres in order to enhance their duplication rate and survival [ 266 ].”

    From Targeting PP2A in cancer: an underrated option (2025) · cites this paper as [266]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [18]Muller HJ The remaking of chromosomes Studies of genetics: The selected papers of HJ Muller 1962 Bloomington Indiana University Press 384 408
  2. [63]Robin JD Ludlow AT Chen M Magdinier F Batten K Holohan B Telomere looping: a new paradigm for the regulation of gene expression with progressive telomere shortening Genes Dev 2014 28 2464 2476 25403178 PMC4233240
  3. [73]Schiffman J Maley CC Nunney L Hochberg M Breen M Cancer across life: Peto’s paradox and the promise of comparative oncology Philos Trans R Soc Lond B Biol Sci. (theme issue) 2015 370 1673 PMC4581022 26056361
  4. [83]Greaves M Ermini L Evolutionary adaptation to risk of cancer: evidence from cancer resistance in elephants JAMA 2015 314 17 1806 1807 26447685
  5. [85]Meeker AK Gage WR Hicks JL Simon I Coffman JR Platz EA Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining Am J Pathol 2002 160 4 1259 1268 11943711 PMC1867217
  6. [104]Holohan B Wright WE Shay JW Impaired telomere maintenance spectrum disorders J Cell Biology 2014 205 3 289 299 PMC4018777 24821837

Cited by

Sorted by citations

Authors
Shay, J. W.
Affiliations
King Abdulaziz University (SA)
Corresponding author
Shay, Jerry W.
Venue
Cancer Discovery
Published
2016-06-01
Volume
6
Issue
6
Pages
584-593
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2321647501
Cited by
668
References
98
Citations by year
2026: 35 · 2025: 69 · 2024: 72 · 2023: 60 · 2022: 69 · 2021: 107 · 2020: 76 · 2019: 66 · 2018: 52 · 2017: 44 · 2016: 13 · 2015: 2 · 2012: 1
FWCI
6.84
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (P50CA70907)
  • Southland Financial Foundation in Geriatrics Research (RO1 AG001228)
  • NIH (C06 RR30414)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
Keywords
telomeres, telomerase, aging, cancer, telomere shortening, telomerase reactivation, telomere length measurement
MeSH terms
Aging, Animals, Cell Transformation, Neoplastic, Humans, Neoplasms, Telomere, Apoptosis, Telomerase, Cell Proliferation, Telomere Homeostasis, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review